Immune events associated with inflammatory bowel disease.
Immunologic abnormalities have been implicated in the etiology of inflammatory bowel disease (IBD). Defects of systemic immunity and of local (intestinal) immunity have been studied. The numbers of T and B lymphocytes and their characteristics seem to vary with the disease, but no cause-and-effect relationship has been established. The presence of anticolon antibodies in patients with ulcerative colitis suggests that these antibodies could be involved in IBD, but they have also been found in other conditions. In the peripheral blood, abnormalities of cell-mediated immunity are inconsistent and suggest that they are not fundamental defects of the disease. The hypothesis that the inflammatory process is a result of immune-mediated intestinal tissue damage is being extensively studied. The high familial incidence of the disease suggests a role of histocompatibility locus antigens, but no reproducible association can be established. In vivo and in vitro studies of mucosal mononuclear cells have revealed abnormalities of immunoglobulin production, some types of cytotoxicity against gut-derived antigens, and altered lymphokine production associated with the disease. Further studies of the intestinal immune system would seem to be the most fruitful line of research.
Fiocchi
C
C
Dept. of Gastroenterology, Cleveland Clinic Foundation, Ohio 44195.
D000917:Antibody Formation; D003092:Colitis / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D006680:HLA Antigens / Q000235:genetics / Q000276:immunology; D049673:History, 20th Century; D006801:Humans; D007111:Immunity, Cellular; D015212:Inflammatory Bowel Diseases / Q000276:immunology*; D007963:Leukocytes, Mononuclear / Q000276:immunology; D009092:Mucous Membrane / Q000166:cytology / Q000276:immunology
D006680:HLA Antigens